Skip to main content
Top
Published in: Journal of Experimental & Clinical Cancer Research 1/2009

Open Access 01-12-2009 | Research

Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck

Authors: Eva Henriksson, Elisabeth Kjellén, Bo Baldetorp, Pär-Ola Bendahl, Åke Borg, Eva Brun, Fredrik Mertens, Tomas Ohlsson, Karin Rennstam, Johan Wennerberg, Peter Wahlberg

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2009

Login to get access

Abstract

Background

The survival of patients with locally advanced head and neck cancer is still poor, with 5-year survival rates of 24–35%. The identification of prognostic and predictive markers at the molecular and cellular level could make it possible to find new therapeutic targets and provide "taylor made" treatments. Established cell lines of human squamous cell carcinoma (HNSCC) are valuable models for identifying such markers.
The aim of this study was to establish and characterize a series of cell lines and to compare the cisplatin sensitivity and 18F fluoro-2 deoxy 2 glucose (18F-FDG) uptake of these cell lines with other cellular characteristics, such as proliferation parameters and TP53 and CCND1 status.

Methods

Explant cultures of fresh tumour tissue were cultivated, and six new permanent cell lines were established from 18 HNSCC cases. Successfully grown cell lines were analysed regarding clinical parameters, histological grade, karyotype, DNA ploidy, and index and S-phase fraction (Spf). The cell lines were further characterized with regard to their uptake of 18F-FDG, their sensitivity to cisplatin, as measured by a viability test (crystal violet), and their TP53 and CCND1 status, by fluorescence in situ hybridization (FISH), polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) with DNA sequencing and, for cyclin D1, by immunohistochemistry.

Results

Patients with tumours that could be cultured in vitro had shorter disease-free periods and overall survival time than those whose tumours did not grow in vitro, when analysed with the Kaplan-Meier method and the log-rank test. Their tumours also showed more complex karyotypes than tumours from which cell lines could not be established. No correlation was found between TP53 or CCND1 status and 18F-FDG uptake or cisplatin sensitivity. However, there was an inverse correlation between tumour cell doubling time and 18F-FDG uptake.

Conclusion

In vitro growth of HNSCC cells seem to be an independent prognostic factor, with cell lines being more readily established from aggressive tumours, a phenomenon more dependent on the molecular genetic characteristics of the tumour cells than on tumour location or TNM status.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferley JAM, Boniol M, Heanue M, Colombet M, Boyle P: Estimates of cancer incidence and mortality in Europe in 2006. Annals of Oncology. 2007, 18: 582-92. Ferley JAM, Boniol M, Heanue M, Colombet M, Boyle P: Estimates of cancer incidence and mortality in Europe in 2006. Annals of Oncology. 2007, 18: 582-92.
2.
go back to reference Vokes EE, Weichselbaum RR, Lippman SM, Hong WK: Head and neck cancer. N Engl J Med. 1993, 3: 184-94. 10.1056/NEJM199301213280306.CrossRef Vokes EE, Weichselbaum RR, Lippman SM, Hong WK: Head and neck cancer. N Engl J Med. 1993, 3: 184-94. 10.1056/NEJM199301213280306.CrossRef
3.
go back to reference Pignon JP, Bourhis J, Domenge C, Designe L: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 2000, 355 (9208): 949-55.CrossRef Pignon JP, Bourhis J, Domenge C, Designe L: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 2000, 355 (9208): 949-55.CrossRef
4.
go back to reference Baldetorp B, Dalberg M, Holst U, Lindgren G: Statistical evaluation of cell kinetic data from DNA flow cytometry (FCM) by the EM algorithm. Cytometry. 1989, 6: 695-705. 10.1002/cyto.990100605.CrossRef Baldetorp B, Dalberg M, Holst U, Lindgren G: Statistical evaluation of cell kinetic data from DNA flow cytometry (FCM) by the EM algorithm. Cytometry. 1989, 6: 695-705. 10.1002/cyto.990100605.CrossRef
5.
go back to reference Schutte B, Reynders MM, Bosman FT, Blijham GH: Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry. 1985, 6 (1): 26-30. 10.1002/cyto.990060106.CrossRef Schutte B, Reynders MM, Bosman FT, Blijham GH: Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry. 1985, 6 (1): 26-30. 10.1002/cyto.990060106.CrossRef
6.
go back to reference Jin C, Mertens F, Jin Y, Wennerberg J, Heim S, Mitelman F: Complex karyotype with an 11q13 homogeneously staining region in esophageal squamous cell carcinoma. Cancer Genet Cytogenet. 1995, 82 (2): 175-6. 10.1016/0165-4608(95)00039-R.CrossRef Jin C, Mertens F, Jin Y, Wennerberg J, Heim S, Mitelman F: Complex karyotype with an 11q13 homogeneously staining region in esophageal squamous cell carcinoma. Cancer Genet Cytogenet. 1995, 82 (2): 175-6. 10.1016/0165-4608(95)00039-R.CrossRef
7.
go back to reference Tanner MM, Tirkkonen M, Kallioniemi A, Collins C, Stokke T, Karhu R, Kowbel D, Shadravan F, Hintz M, Kuo W, Waldman FM, Isola JJ: Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res. 1994, 54 (16): 4257-60. Tanner MM, Tirkkonen M, Kallioniemi A, Collins C, Stokke T, Karhu R, Kowbel D, Shadravan F, Hintz M, Kuo W, Waldman FM, Isola JJ: Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res. 1994, 54 (16): 4257-60.
8.
go back to reference Fioretos T, Strombeck B, Sandberg T, Johansson B, Billstrom R, Borg A, Nilsson PG, Berghe HVD, Hagemeijer A, Mitelman F, Höglund M: Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations. Blood. 1999, 94 (1): 225-32. Fioretos T, Strombeck B, Sandberg T, Johansson B, Billstrom R, Borg A, Nilsson PG, Berghe HVD, Hagemeijer A, Mitelman F, Höglund M: Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations. Blood. 1999, 94 (1): 225-32.
9.
go back to reference Henriksson E, Kjellen E, Wahlberg P, Wennerberg J, Kjellstrom JH: Differences in estimates of cisplatin-induced cell kill in vitro between colorimetric and cell count/colony assays. In Vitro Cell Dev Biol Anim. 2006, 42 (10): 320-3. Henriksson E, Kjellen E, Wahlberg P, Wennerberg J, Kjellstrom JH: Differences in estimates of cisplatin-induced cell kill in vitro between colorimetric and cell count/colony assays. In Vitro Cell Dev Biol Anim. 2006, 42 (10): 320-3.
10.
go back to reference Pekkola K, Raikka A, Joensuu H, Minn H, Aitasalo K, Grenman R: Permanent in vitro growth is associated with poor prognosis in head and neck cancer. Acta Otolaryngol. 2004, 124 (2): 192-6. 10.1080/00016480310015209.CrossRef Pekkola K, Raikka A, Joensuu H, Minn H, Aitasalo K, Grenman R: Permanent in vitro growth is associated with poor prognosis in head and neck cancer. Acta Otolaryngol. 2004, 124 (2): 192-6. 10.1080/00016480310015209.CrossRef
11.
go back to reference Johns ME, Mills MS: Cloning efficiency. A possible prognostic indicator in squamous cell carcinoma of head and neck. Cancer. 1983, 52 (8): 1401-4. 10.1002/1097-0142(19831015)52:8<1401::AID-CNCR2820520811>3.0.CO;2-7.CrossRef Johns ME, Mills MS: Cloning efficiency. A possible prognostic indicator in squamous cell carcinoma of head and neck. Cancer. 1983, 52 (8): 1401-4. 10.1002/1097-0142(19831015)52:8<1401::AID-CNCR2820520811>3.0.CO;2-7.CrossRef
12.
go back to reference Johns M: The clonal assay of head and neck tumor cells: results and clinical correlations. Laryngoscope. 1982, 92 (7 Pt 2 Suppl 28): 1-26. 10.1288/00005537-198207001-00001.CrossRef Johns M: The clonal assay of head and neck tumor cells: results and clinical correlations. Laryngoscope. 1982, 92 (7 Pt 2 Suppl 28): 1-26. 10.1288/00005537-198207001-00001.CrossRef
13.
go back to reference Kim SYCK, Lee HR, Lee KS, Carey TE: Establishment and characterization of nine new head and neck cancer cell lines. Acta Otolaryngol. 1997, 117 (5): 775-84. 10.3109/00016489709113477.CrossRef Kim SYCK, Lee HR, Lee KS, Carey TE: Establishment and characterization of nine new head and neck cancer cell lines. Acta Otolaryngol. 1997, 117 (5): 775-84. 10.3109/00016489709113477.CrossRef
14.
go back to reference Mattox DE, Von Hoff DD, Clark GM, Aufdemorte TB: Factors that influence growth of head and neck squamous carcinoma in the soft agar cloning assay. Cancer. 1984, 53 (8): 1736-40. 10.1002/1097-0142(19840415)53:8<1736::AID-CNCR2820530820>3.0.CO;2-1.CrossRef Mattox DE, Von Hoff DD, Clark GM, Aufdemorte TB: Factors that influence growth of head and neck squamous carcinoma in the soft agar cloning assay. Cancer. 1984, 53 (8): 1736-40. 10.1002/1097-0142(19840415)53:8<1736::AID-CNCR2820530820>3.0.CO;2-1.CrossRef
15.
go back to reference Akervall JA, Jin Y, Wennerberg JP, Zatterstrom UK, Kjellen E, Mertens F, Wennerberg J: Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer. 1995, 76 (5): 853-9. 10.1002/1097-0142(19950901)76:5<853::AID-CNCR2820760520>3.0.CO;2-6.CrossRef Akervall JA, Jin Y, Wennerberg JP, Zatterstrom UK, Kjellen E, Mertens F, Wennerberg J: Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer. 1995, 76 (5): 853-9. 10.1002/1097-0142(19950901)76:5<853::AID-CNCR2820760520>3.0.CO;2-6.CrossRef
16.
go back to reference Arai Y, Tsukuda M, Ito K, Enomoto H, Furukawa M, Kubota A, Yanoma S, Okamoto N: Analysis of DNA ploidy using fresh frozen tissues of head and neck squamous cell carcinomas. Auris Nasus Larynx. 1997, 24 (2): 193-8. 10.1016/S0385-8146(96)00018-1.CrossRef Arai Y, Tsukuda M, Ito K, Enomoto H, Furukawa M, Kubota A, Yanoma S, Okamoto N: Analysis of DNA ploidy using fresh frozen tissues of head and neck squamous cell carcinomas. Auris Nasus Larynx. 1997, 24 (2): 193-8. 10.1016/S0385-8146(96)00018-1.CrossRef
17.
go back to reference Rubio Bueno P, Naval Gias L, Garcia Delgado R, Domingo Cebollada J, Diaz Gonzalez FJ: Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the oral cavity and tongue base. Head & Neck. 1998, 20 (3): 232-39. 10.1002/(SICI)1097-0347(199805)20:3<232::AID-HED8>3.0.CO;2-1.CrossRef Rubio Bueno P, Naval Gias L, Garcia Delgado R, Domingo Cebollada J, Diaz Gonzalez FJ: Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the oral cavity and tongue base. Head & Neck. 1998, 20 (3): 232-39. 10.1002/(SICI)1097-0347(199805)20:3<232::AID-HED8>3.0.CO;2-1.CrossRef
18.
go back to reference Goldsmith MM, Cresson DH, Arnold LA, Postma DS, Askin FB, Pillsbury HC: DNA flow cytometry as a prognostic indicator in head and neck cancer. Otolaryngol Head Neck Surg. 1987, 96 (4): 307-18. Goldsmith MM, Cresson DH, Arnold LA, Postma DS, Askin FB, Pillsbury HC: DNA flow cytometry as a prognostic indicator in head and neck cancer. Otolaryngol Head Neck Surg. 1987, 96 (4): 307-18.
19.
go back to reference Borst GR, Belderbos JS, Boellaard R, Comans EF, De Jaeger K, Lammertsma AA, Lebesque JV: Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer. Eur J Cancer. 2005, 41 (11): 1533-41. 10.1016/j.ejca.2005.03.026.CrossRef Borst GR, Belderbos JS, Boellaard R, Comans EF, De Jaeger K, Lammertsma AA, Lebesque JV: Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer. Eur J Cancer. 2005, 41 (11): 1533-41. 10.1016/j.ejca.2005.03.026.CrossRef
20.
go back to reference Sperti C, Pasquali C, Chierichetti F, Ferronato A, Decet G, Pedrazzoli S: 18-Fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma. J Gastrointest Surg. 2003, 7 (8): 953-9. 10.1016/j.gassur.2003.09.002. discussion 59–60.CrossRef Sperti C, Pasquali C, Chierichetti F, Ferronato A, Decet G, Pedrazzoli S: 18-Fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma. J Gastrointest Surg. 2003, 7 (8): 953-9. 10.1016/j.gassur.2003.09.002. discussion 59–60.CrossRef
21.
go back to reference Halfpenny W, Hain SF, Biassoni L, Maisey MN, Sherman JA, McGurk M: FDG-PET. A possible prognostic factor in head and neck cancer. Br J Cancer. 2002, 86 (4): 512-6. 10.1038/sj.bjc.6600114.CrossRef Halfpenny W, Hain SF, Biassoni L, Maisey MN, Sherman JA, McGurk M: FDG-PET. A possible prognostic factor in head and neck cancer. Br J Cancer. 2002, 86 (4): 512-6. 10.1038/sj.bjc.6600114.CrossRef
22.
go back to reference Kunkel M, Reichert TE, Benz P, Lehr HA, Jeong JH, Wieand S, Bartenstein P, Wagner W, Whiteside TL: Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer. 2003, 97 (4): 1015-24. 10.1002/cncr.11159.CrossRef Kunkel M, Reichert TE, Benz P, Lehr HA, Jeong JH, Wieand S, Bartenstein P, Wagner W, Whiteside TL: Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer. 2003, 97 (4): 1015-24. 10.1002/cncr.11159.CrossRef
23.
go back to reference Brun E, Kjellen E, Tennvall J, Ohlsson T, Sandell A, Perfekt R, Wennerberg J, Strand SE: FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck. 2002, 24 (2): 127-35. 10.1002/hed.10037.CrossRef Brun E, Kjellen E, Tennvall J, Ohlsson T, Sandell A, Perfekt R, Wennerberg J, Strand SE: FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck. 2002, 24 (2): 127-35. 10.1002/hed.10037.CrossRef
24.
go back to reference Schoder H, Yeung HW: Positron emission imaging of head and neck cancer, including thyroid carcinoma. Semin Nucl Med. 2004, 34 (3): 180-97. 10.1053/j.semnuclmed.2004.03.004.CrossRef Schoder H, Yeung HW: Positron emission imaging of head and neck cancer, including thyroid carcinoma. Semin Nucl Med. 2004, 34 (3): 180-97. 10.1053/j.semnuclmed.2004.03.004.CrossRef
25.
go back to reference Smith TA, Titley JC, McCready VR: Proliferation is associated with 2-deoxy-D-[1-3H]glucose uptake by T47D breast tumour and SW480 and SW620 colonic tumour cells. Nucl Med Biol. 1998, 25 (5): 481-5. 10.1016/S0969-8051(98)00014-6.CrossRef Smith TA, Titley JC, McCready VR: Proliferation is associated with 2-deoxy-D-[1-3H]glucose uptake by T47D breast tumour and SW480 and SW620 colonic tumour cells. Nucl Med Biol. 1998, 25 (5): 481-5. 10.1016/S0969-8051(98)00014-6.CrossRef
26.
go back to reference Minn H, Joensuu H, Ahonen A, Klemi P: Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors. Cancer. 1988, 61 (9): 1776-81. 10.1002/1097-0142(19880501)61:9<1776::AID-CNCR2820610909>3.0.CO;2-7.CrossRef Minn H, Joensuu H, Ahonen A, Klemi P: Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors. Cancer. 1988, 61 (9): 1776-81. 10.1002/1097-0142(19880501)61:9<1776::AID-CNCR2820610909>3.0.CO;2-7.CrossRef
27.
go back to reference Smith TA, Titley J: Deoxyglucose uptake by a head and neck squamous carcinoma: influence of changes in proliferative fraction. Int J Radiat Oncol Biol Phys. 2000, 47 (1): 219-23.CrossRef Smith TA, Titley J: Deoxyglucose uptake by a head and neck squamous carcinoma: influence of changes in proliferative fraction. Int J Radiat Oncol Biol Phys. 2000, 47 (1): 219-23.CrossRef
28.
go back to reference Jacob R, Welkoborsky HJ, Mann WJ, Jauch M, Amedee R: [Fluorine-18] fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous-cell carcinomas of the head and neck. ORL J Otorhinolaryngol Relat Spec. 2001, 63 (5): 307-13.CrossRef Jacob R, Welkoborsky HJ, Mann WJ, Jauch M, Amedee R: [Fluorine-18] fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous-cell carcinomas of the head and neck. ORL J Otorhinolaryngol Relat Spec. 2001, 63 (5): 307-13.CrossRef
29.
go back to reference Watanabe K, Nomori H, Ohtsuka T, Naruke T, Ebihara A, Orikasa H, Yamazaki K, Uno K, Kobayashi T, Goya T: [F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas. Jpn J Clin Oncol. 2006, 36 (7): 403-9. 10.1093/jjco/hyl043.CrossRef Watanabe K, Nomori H, Ohtsuka T, Naruke T, Ebihara A, Orikasa H, Yamazaki K, Uno K, Kobayashi T, Goya T: [F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas. Jpn J Clin Oncol. 2006, 36 (7): 403-9. 10.1093/jjco/hyl043.CrossRef
30.
go back to reference Smith TA, Sharma RI, Thompson AM, Paulin FE: Tumor 18F-FDG incorporation is enhanced by attenuation of P53 function in breast cancer cells in vitro. J Nucl Med. 2006, 47 (9): 1525-30. Smith TA, Sharma RI, Thompson AM, Paulin FE: Tumor 18F-FDG incorporation is enhanced by attenuation of P53 function in breast cancer cells in vitro. J Nucl Med. 2006, 47 (9): 1525-30.
31.
go back to reference Zhou S, Kachhap S, Singh KK: Mitochondrial impairment in p53-deficient human cancer cells. Mutagenesis. 2003, 18 (3): 287-92. 10.1093/mutage/18.3.287.CrossRef Zhou S, Kachhap S, Singh KK: Mitochondrial impairment in p53-deficient human cancer cells. Mutagenesis. 2003, 18 (3): 287-92. 10.1093/mutage/18.3.287.CrossRef
Metadata
Title
Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck
Authors
Eva Henriksson
Elisabeth Kjellén
Bo Baldetorp
Pär-Ola Bendahl
Åke Borg
Eva Brun
Fredrik Mertens
Tomas Ohlsson
Karin Rennstam
Johan Wennerberg
Peter Wahlberg
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2009
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/1756-9966-28-17

Other articles of this Issue 1/2009

Journal of Experimental & Clinical Cancer Research 1/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine